Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome - Physiopathologie Cardiovasculaire et Mitochondriale
Article Dans Une Revue Experimental Hematology & Oncology Année : 2022

Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome

Résumé

VEXAS (vacuoles, E1 enzyme, X-linked, auto-inflammatory, somatic) syndrome is an inflammatory disorder with hematological and systemic features. A recent study demonstrated that the dermal infiltrate in neutrophilic dermatosis from VEXAS patients is derived from the pathological UBA1 -mutated myeloid clone. Neutrophilic dermatosis is, however, only one of the various skin involvements observed in VEXAS syndrome. We analyzed 10 formalin-fixed paraffin-embedded skin biopsies from genetically confirmed VEXAS syndrome. UBA1 mutation was found in the biopsies related to neutrophilic dermatitis but in none of the other histological patterns (leukocytoclastic vasculitis and septal panniculitis). This could lead to a distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome, which could in turn improve therapeutic outcomes.
Fichier principal
Vignette du fichier
40164_2022_Article_262.pdf (754.74 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
licence

Dates et versions

hal-04756993 , version 1 (28-10-2024)

Licence

Identifiants

Citer

Valentin Lacombe, Annaelle Beucher, Geoffrey Urbanski, Yannick Le Corre, Laurane Cottin, et al.. Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome. Experimental Hematology & Oncology, 2022, 11 (1), pp.6. ⟨10.1186/s40164-022-00262-5⟩. ⟨hal-04756993⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More